No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial
Authors
Keywords
Major depressive disorder, Randomised controlled trial, Inflammation, Antidepressant, Anti-inflammatory medication
Journal
EUROPEAN NEUROPSYCHOPHARMACOLOGY
Volume 53, Issue -, Pages 34-46
Publisher
Elsevier BV
Online
2021-08-08
DOI
10.1016/j.euroneuro.2021.07.092
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psychological training to improve psychosocial function in patients with major depressive disorder: A randomised clinical trial
- (2021) Matthew J. Knight et al. PSYCHIATRY RESEARCH
- Antidepressants of different classes cause distinct behavioral and brain pro- and anti-inflammatory changes in mice submitted to an inflammatory model of depression
- (2020) Viviane de Sousa Tomaz et al. JOURNAL OF AFFECTIVE DISORDERS
- Design, synthesis and biological evaluation of vortioxetine derivatives as new COX-1/2 inhibitors in human monocytes
- (2020) Maria Talmon et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Brain-immune crosstalk in the treatment of major depressive disorder
- (2020) Igor Branchi et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Clinical Switching Strategies of Various Antidepressants to Vortioxetine in the PREDDICT Trial
- (2020) Natalie T Mills et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Neuroinflammation and cognition across psychiatric conditions
- (2019) Célia Fourrier et al. CNS SPECTRUMS
- Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials
- (2019) O. Köhler‐Forsberg et al. ACTA PSYCHIATRICA SCANDINAVICA
- Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue
- (2019) Daniela Enache et al. BRAIN BEHAVIOR AND IMMUNITY
- Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium
- (2019) Gara Arteaga-Henríquez et al. Frontiers in Psychiatry
- Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis
- (2019) Jia Jia Liu et al. MOLECULAR PSYCHIATRY
- Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders
- (2019) Gayle M. Wittenberg et al. MOLECULAR PSYCHIATRY
- The efficacy of anti-inflammatory treatment interventions on depression in individuals with major depressive disorder and high levels of inflammation: A systematic review of randomized clinical trials
- (2019) David J. Allison et al. PHYSIOLOGY & BEHAVIOR
- Rapeseed oil fortified with micronutrients improves cognitive alterations associated with metabolic syndrome
- (2019) Célia Fourrier et al. BRAIN BEHAVIOR AND IMMUNITY
- Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials
- (2019) Shuang Bai et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Large-scale evidence for an association between low-grade peripheral inflammation and brain structural alterations in major depression in the BiDirect study
- (2019) Nils Opel et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study
- (2018) Bernhard T. Baune et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials
- (2018) Joshua D. Rosenblat et al. JOURNAL OF AFFECTIVE DISORDERS
- Interleukin, tumor necrosis factor-α and C-reactive protein profiles in melancholic and non-melancholic depression: A systematic review
- (2018) Chenghao Yang et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- The anti-inflammatory mechanism of antidepressants – SSRIs, SNRIs
- (2018) Piotr Gałecki et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo
- (2018) Célia Fourrier et al. Trials
- The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction
- (2017) Roger S. McIntyre et al. JOURNAL OF CLINICAL PSYCHIATRY
- Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis
- (2017) Muhammad I Husain et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
- (2016) D R Goldsmith et al. MOLECULAR PSYCHIATRY
- Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions
- (2016) N Kappelmann et al. MOLECULAR PSYCHIATRY
- Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression
- (2016) H. Eyre et al. PHARMACOPSYCHIATRY
- So depression is an inflammatory disease, but where does the inflammation come from?
- (2016) Michael Berk et al. BMC Medicine
- Vortioxetine: a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder
- (2015) Mayce Al-Sukhni et al. Expert Opinion On Drug Safety
- A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression
- (2015) Harris A. Eyre et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials
- (2014) Farhad Faridhosseini et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Prophylactic Antidepressant Treatment of Interferon-Induced Depression in Chronic Hepatitis C
- (2014) Marc Udina et al. JOURNAL OF CLINICAL PSYCHIATRY
- A phase-specific neuroimmune model of clinical depression
- (2014) H.A. Eyre et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects
- (2014) Ole Köhler et al. JAMA Psychiatry
- Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis
- (2013) Kyoung-Sae Na et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
- (2012) Seyed-Hesameddin Abbasi et al. JOURNAL OF AFFECTIVE DISORDERS
- Stability and transitions of depressive subtypes over a 2-year follow-up
- (2012) F. Lamers et al. PSYCHOLOGICAL MEDICINE
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- Immune system to brain signaling: Neuropsychopharmacological implications
- (2011) Lucile Capuron et al. PHARMACOLOGY & THERAPEUTICS
- A Meta-Analysis of Cytokines in Major Depression
- (2009) Yekta Dowlati et al. BIOLOGICAL PSYCHIATRY
- Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial
- (2009) Shahin Akhondzadeh et al. DEPRESSION AND ANXIETY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started